A FDA advisory panel recommended that the administration not approve a new pain drug called Moxduo that combines morphine and oxycodone. The panel voted 14 to zero against the approval of the drug.
QRXPharma developed the combination pill with a goal to decrease dangerous side effects of prescription painkillers, such as breathing problems and vomiting. But the panel agreed that there was no data proving the drug was safer than taking morphine and oxycodone separately.
Doctors also worried that since the pill can be eaisly crushed it could be abused by painkiller addicts.